מקדם חוב לטווח ארוך להון 180lifesciences.com (ETHZ)

The price trajectory of ETHZilla Corp (ETHZ) on the GURU.Markets platform is 1.09, reflecting delisting risks and a financial crisis should the development vector shift. The business relies on the development of antibodies against tumor factors and possesses significant pricing power. However, the synthesis of biomedicine and digital currencies leaves the quotes vulnerable to global instability and sharp spikes in crypto assets.

ETHZilla Corp (ETHZ) is scaling its crypto infrastructure and Web3 assets through strategic mergers and tokenization partnerships. This ratio of liabilities over one year to equity digitizes the debt load, comparing long-term borrowings with total capital to assess financial stability and expansion rates, where a stable trend confirms the maturity of the financing structure, while a sharp decline may signal a decrease in investment activity.